How to cite item

A mighty oak in the rapidly expanding field of checkpoint inhibition for NSCLC

   
@article{JTD12412,
	author = {Petros Christopoulos and Michael Thomas},
	title = {A mighty oak in the rapidly expanding field of checkpoint inhibition for NSCLC},
	journal = {Journal of Thoracic Disease},
	volume = {9},
	number = {3},
	year = {2017},
	keywords = {},
	abstract = {In the Lancet issue of last December Rittmeyer and colleagues reported the primary efficacy analysis of another landmark immunotherapy study (1): the randomized phase 3 OAK trial comparing atezolizumab (n=425), an anti-programmed death-ligand 1 (PD-L1) monoclonal antibody, with docetaxel (n=425) for patients with squamous or adenocarcinomatous non-small cell lung cancer (NSCLC) progressing after one or more platinum-based combination regimens.},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/12412}
}